(ARQT) |
| 0 (0%) 08-02 22:19 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 29.84 |
| Resistance 1: | 28.09 |
| Pivot price: | 27.69 |
| Support 1: | 25.25 |
| Support 2: | 21.01 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.020 |
| Book Value | 1.520 |
| PEG Ratio | 0.00 |
| Gross Profit | 3.022 |
| Profit Margin (%) | -0.57 |
| Operating Margin (%) | -8.62 |
| Return on Assets (ttm) | 0.5 |
| Return on Equity (ttm) | -1.4 |
Company news
Fri, 31 Jul 2026
Arcutis Biotherapeutics (ARQT) Stock Trades At A Discount To Sales But Fair Value Looks Tight - Yahoo Finance
Fri, 31 Jul 2026
Arcutis Biotherapeutics (ARQT) Heads Into Earnings With Its ZORYVE Story Still Shaping Valuation - Yahoo Finance
Wed, 29 Jul 2026
Is Arcutis (ARQT) Quietly Reframing Its Strategy With Mirum CEO Chris Peetz on the Board? - simplywall.st
Wed, 29 Jul 2026
Stocks Turn Tail After Fed Holds Rates Steady; STX, SNOW, ARQT In Focus - Investor's Business Daily
Wed, 29 Jul 2026
Arcutis Biotherapeutics, Inc. (ARQT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Sat, 25 Jul 2026
Arcutis Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:ARQT - TradingView
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
